Treatment of uterine cancer and ovarian cancer with a PARP inhibitor alone or in combination with anti-tumor agents

Details for Australian Patent Application No. 2008321382 (hide)

Owner BIPAR SCIENCES, INC.

Inventors Bradley, Charles; Sherman, Barry; Ossovskaya, Valeria

Agent A J Park

Pub. Number AU-A-2008321382

PCT Pub. Number WO2009/064444

Priority 61/012,364 07.12.07 US; 60/987,335 12.11.07 US; 61,058,528 03.06.08 US

Filing date 12 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/66 (2006.01) - Phosphorus compounds

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/064444 Priority application(s): WO2009/064444

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321385-Method and apparatus for storing and transporting portable stationary sheet flow water rides

2008321381-Combination EAS and RFID label or tag with controllable read range using a hybrid RFID antenna